2019
DOI: 10.21037/jtd.2018.12.65
|View full text |Cite
|
Sign up to set email alerts
|

The del Nido cardioplegia in adult cardiac surgery: reinventing myocardial protection?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
4
0
2

Year Published

2021
2021
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 11 publications
0
4
0
2
Order By: Relevance
“…It is a calciumfree solution and delivered in a ratio of four parts crystalloid to one part blood [3]. Since its initial use in paediatric cardiac surgery, favourable results have been found in patients undergoing adult cardiac surgery [1]. However, the cardioplegia solution was initially developed for myocardial protection in children, in whom the heart is more resistant to ischaemia and in whom the coronaries are not diseased.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…It is a calciumfree solution and delivered in a ratio of four parts crystalloid to one part blood [3]. Since its initial use in paediatric cardiac surgery, favourable results have been found in patients undergoing adult cardiac surgery [1]. However, the cardioplegia solution was initially developed for myocardial protection in children, in whom the heart is more resistant to ischaemia and in whom the coronaries are not diseased.…”
Section: Discussionmentioning
confidence: 99%
“…Myocardial protection is essential in cardiac surgery. Of the various methods of myocardial protection, administration of cardioplegia is the most important [1]. Arresting the heart in diastole with hyperkalaemic solutions reduces myocardial oxygen consumption, and allows the surgeon to operate in a still and quiet field [2].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Many studies involving cardiac surgeries performed with dNCS report that it is a and superior cardioplegia solution and technique in terms of aortic cross clamp duration, cardiopulmonary bypass time, required cardioplegia solution volume and cardiac and many organ and biochemical parameters [23][24][25]. In a meta-analysis including 5516 patients from 10 randomized controlled studies, including a larger patient and study series, and 13 cohort studies with propensity-score match analysis, authors revealed that dNCS shortened operation times compared to multidose cardioplegia, while decreasing reperfusion-related fibrillation rates, and postoperative cardiac enzyme levels [26].…”
Section: Advantages and Disadvantages Of Del Nido Cardioplegia Solution Advantagesmentioning
confidence: 99%
“…Během posledních desetiletí jsou základními pilíři ochrany myokardu vyprázdnění -unloading -srdce během mimotělního oběhu, hypotermie a zástava srdce pomocí roztoku s vysokým obsahem draslíku. 4 Možnost použití hyperkalemické kardioplegie poprvé uveřejnil D. G. Melrose (1955) v experimentu na psech při použití citrátu draselného. 5 Principem je zde zvýšení membránového potenciálu dodaným roztokem a inaktivace rychlých sodíkových kanálů potřebných ke spuštění akčního potenciálu kardiomyocytů; dochází tak k zástavě srdce v diastole.…”
Section: Kardioplegický Roztokunclassified